Test bank for pharmacotherapeutics for advanced practice A practical approach 5th edition by Virginia P. Arcangelo All Chapters 1-56

Test bank
pharmacotherapeutics for advanced practice
A practical approach 5th edition
by Virginia P. Arcangelo All Chapters 1-56

,ggg


ggggggggg TABLE OF CONTENT
g g




o Chapter g 1: gIssues g for gthe gPractitioner gin gDrug g Therapy
o Chapter g 2: gPharmacokinetic g Basis gofgTherapeutics gand gPharmacodynamic gPrinciples
o Chapter g 3: gImpact gofgDrug gInteractions gand gAdverse gEvents g on gTherapeutics
o Chapter g 4: gPrinciples g of g Pharmacotherapy gin gPediatrics, gPregnancy gand gLactation
o Chapter g 5: gPharmacotherapy gPrinciples g in gOlder g Adults
o Chapter g 6: gPrinciples g of g Antimicrobial gTherapy
o Chapter g 7: gPharmacogenomics g
o Chapter g 8: g The g Economics gofgPharmacotherapeutics
o Chapter g 9: gPrinciples g of g Pharmacology g in gPain g Management
o Chapter g 10: gPain g Management g in gOpioid gUse gDisorder g(OUD) gPatients
o Chapter g 11: g Cannabis g and gPain g Management
o Chapter g 12: gDermatitis
o Chapter g 13: g Bacterial, gFungal, gand g Viral gInfections g of gthe g Skin g
o Chapter g 14: gPsoriasis
o Chapter g 15: gAcne gVulgaris gand gRosacea
o Chapter g 16: gOphthalmic gDisorders
o Chapter g 17: gOtitis g Media gand gOtitis gExterna
o Chapter g 18: gHypertension
o Chapter g 19: gHyperlipidemia
o Chapter g 20: g Chronic g Stable gAngina gand gMyocardial gInfarction
o Chapter g 21: gHeart g Failure
o Chapter g 22: gArrhythmias
o Chapter g 23: gRespiratory g Infections
o Chapter g 24: gAsthma gand gChronic gObstructive gPulmonary gDisease
o Chapter g 25: ggGastric, gFunctional gand gInflammatory gBowel gDisorders
o Chapter g 26: g Gastroesophageal gReflux gDisease g and gPeptic gUlcer gDisease
o Chapter g 27: gLiver gDiseases
o Chapter g 28: ggUrinary gTract gInfection
o Chapter g 29: ggProstatic gDisorders gand gErectile gDysfunction
o Chapter g 30: gOveractive g Bladder
o Chapter g 31: g Sexually gTransmitted gInfections
o Chapter g 32: gOsteoarthritis gand g Gout
o Chapter g 33: gOsteoporosis

,o Chapter g 34: gRheumatoid gArthritis
o Chapter g 35: gHeadaches
o Chapter g 36: g Seizure gDisorders
o Chapter g 37: gAlzheimer’s gDisease
o Chapter g 38: gParkinson gDisease
o Chapter g 39: g Major gDepressive gDisorder gand g Bipolar gDisorders
o Chapter g 40: gAnxiety gDisorders
o Chapter g 41: g Sleep gDisorders
o Chapter g 42: gAttention gDeficit gHyperactivity gDisorder
o Chapter g 43: g Substance g Use gDisorders
o Chapter g 44: gDiabetes g Mellitus
o Chapter g 45: gThyroid gand g Parathyroid gDisorders
o Chapter g 46: gAllergies g and gAllergic g Reactions
o Chapter g 47: gHuman gImmunodeficiency gVirus
o Chapter g 48: gOrgan gTransplantation
o Chapter g 49: gPharmacotherapy gfor gSelect gThromboembolic gDisorders
o Chapter g 50: gAnemias
o Chapter g 51: gImmunizations
o Chapter g 52: g Smoking g Cessation
o Chapter g 53: gWeight gLoss
o Chapter g 54: g Contraception
o Chapter g 55: g Menopause
o Chapter g 56: gVaginitis

, Chapter 1 Issues for the Practitioner in Drug Therapy
g g g g g g g g




MULTIPLEgCHOICE

1. Nursegpractitionergprescriptivegauthoritygisgregulatedgby:
A. ThegNationalgCouncilgofgStategBoardsgofgNursing
B. ThegU.S.gDruggEnforcementgAdministration
C. ThegStategBoardgofgNursinggforgeachgstate
D. ThegStategBoardgofgPharmacy

ANS:g C PTS:g g 1

2. PhysiciangAssistantg(PA)gprescriptivegauthoritygisgregulatedgby:
A. ThegNationalgCouncilgofgStategBoardsgofgNursing
B. ThegU.S.gDruggEnforcementgAdministration
C. ThegStategBoardgofgNursing
D. ThegStategBoardgofgMedicalgExaminers

ANS:g D PTS:g g 1

3. Clinicalgjudgmentgingprescribinggincludes:
A. Factoringgingthegcostgtogthegpatientgofgthegmedicationgprescribed
B. Alwaysgprescribinggthegnewestgmedicationgavailablegforgthegdiseasegprocess
C. Handinggoutgdruggsamplesgtogpoorgpatients
D. Prescribinggallggenericgmedicationsgtogcutgcosts
ANS:g A PTS:g g 1

4. Criteriagforgchoosinggangeffectivegdruggforgagdisorderginclude:
A. Askinggthegpatientgwhatgdruggtheygthinkgwouldgworkgbestgforgthem
B. Consultinggnationallygrecognizedgguidelinesgforgdiseasegmanagement
C. Prescribinggmedicationsgthatgaregavailablegasgsamplesgbeforegwritinggagprescription
D. FollowinggU.S.gDruggEnforcementgAdministrationg(DEA)gguidelinesgforgpre
scribing
ANS:g B PTS:g g 1

5. Nursegpractitionergpracticegmaygthrivegunderghealth-caregreformgduegto:
A. Thegdemonstratedgabilitygofgnursegpractitionersgtogcontrolgcostsgandgimprovegpatientg
outcomes
B. Thegfactgthatgnursegpractitionersgwillgbegablegtogpracticegindependently
C. Thegfactgthatgnursegpractitionersgwillghavegfullgreimbursementgunderghealth-
caregreform
D. ThegabilitygtogshiftgaccountabilitygforgMedicaidgtogthegstateglevel
ANS:g A PTS:g g 1